References
Salani R, Diaz-Montes T, Giuntoli RL, Bristow RE. Surgical management of mesenteric lymph node metastasis in patients undergoing rectosigmoid colectomy for locally advanced ovarian carcinoma. Ann Surg Oncol. 2007;14:3552–7.
Tanaka K, Shimada Y, Nishino K, et al. Clinical significance of mesenteric lymph node involvement in the pattern of liver metastasis in patients with ovarian cancer. Ann Surg Oncol. https://doi.org/10.1245/s10434-021-09899-8.
Perren TJ, Swart AM, Pfisterer J, et al. A phase 3 trial of bevacizumab in ovarian cancer. N Engl J Med. 2011;365:2484–96.
Burger RA, Brady MF, Bookman MA, et al. Incorporation of bevacizumab in the primary treatment of ovarian cancer. N Engl J Med. 2011;365:2473–83.
O’Neill AC, Somarouthu B, Tirumani SH, et al. Patterns and prognostic importance of hepatic involvement in patients with serous ovarian cancer: a single-institution experience with 244 patients. Radiology. 2017;282:160–70.
Acknowledgments
This research was supported by JSPS KAKENHI Grant Number JP19K09116 (MN, YS, HK, TW, KN, TE, KY, and KT).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Yoshifumi Shimada, Kana Tanaka, Koji Nishino, Kosuke Yoshihara, Masato Nakano, Hitoshi Kameyama, Takayuki Enomoto, and Toshifumi Wakai have no potential conflicts of interest to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Shimada, Y., Tanaka, K., Nishino, K. et al. ASO Author Reflections: Clinical Significance of Mesenteric Lymph Node Involvement in Patients with Ovarian Cancer. Ann Surg Oncol 28, 7614–7615 (2021). https://doi.org/10.1245/s10434-021-09919-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-021-09919-7